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Introduction: A multicenter prospective study was conducted to evaluate a new strategy
for multiple Ventricular Septal Defects (VSDs).
Materials and Methods: From 2004 to 2012 17 consecutive children (3 premature,
14 infants), mean age 3.2 months (9 days–9 months), mean body weight 4.2 kg (3.1–
6.1 kg), with multiple VSDs underwent Pulmonary Artery Banding (PAB) with an adjustable
FloWatch-PAB®. Associated cardiac anomalies included patent ductus arteriosus (1),
aortic coarctation (2), hypoplastic aortic arch (2), and left isomerism (3). Five patients
(5/17=29.4%) required pre-operative mechanical ventilation, with a mean duration of
64 days (7–240 days)
Results: There were no early or late deaths during a mean follow-up of 48 months (7–
98 months), with either FloWatch removal or last observation as end-points. FloWatch-
PAB® adjustments were required in all patients: a mean of 4.8 times/patient (2–9) to
tighten the PAB, and a mean of 1.1 times/patient (0–3) to release the PAB with the patient’s
growth. After a mean interval of 29 months (8–69 months) 10/17 (59%) patients underwent
re-operation: 7/10 PAB removal, with closure of a remaining unrestrictive VSD in 6 (peri-
membranous in 3 patients, mid-muscular in 2, and inlet in 1) and Damus–Kaye–Stansel,
bi-directional Glenn, and atrial septectomy in 1; 3/9 patients required only PAB removal. All
muscular multiple VSDs had closed in all 10 patients. PA reconstruction was required in
1/10 patient. In 5/7 of the remaining patients with the PAB still in situ, all muscular VSDs
had already closed. The only 2 patients with persistent muscular multiple VSDs are the 2
patients with the shortest follow-up.
Conclusion: This reproducible new strategy with an adjustable PAB simplifies the man-
agement of infants with multiple VSDs and provides the following advantages: (a) good
results (0% mortality), delayed surgery with a high incidence (15/17=88%) of sponta-
neous closure of multiple muscular VSDs, and facilitated closure of residual unrestrictive
VSD (peri-membranous, mid-muscular, or inlet) at an older age and higher body weight;
PAB with FloWatch-PAB® and its subsequent removal can potentially be the only proce-
dure required for Swiss cheese multiple VSDs without an associated peri-membranous
unrestrictive VSD.
Keywords: congenital heart defects, multiple ventricular septal defects, palliation, pulmonary artery banding,
surgical repair
INTRODUCTION
Multiple muscular Ventricular Septal Defects (VSDs) are defined
as the presence of more than oneVSD in the muscular septum,with
or without other VSD located in the peri-membranous or outlet
septum, with or without associated intra-cardiac or extra-cardiac
malformations (3).
Conventional surgical repair of multiple muscular VSDs is gen-
erally accompanied by substantial early and late mortality and
morbidity (1, 2, 4–21).
The hospital mortality with conventional repair has been
reported in the literature to be between 0 and 14.2% (1, 2, 4–
21). In the 192 patients reported in the Congenital Database of
the European Association of Cardio-Thoracic Surgery the hospital
mortality was 8.5%1.
In the previous decade an alternative approach with intra-
operative device closure reported unsatisfactory initial over-
all results due to elevated mortality (14–25%) and high fail-
ure rates (20–40%) (22–25). More recently institutions with
advanced facilities for hybrid techniques have reported encour-
aging outcomes in selected series of multiple VDSs closure
(26–30).
1www.eactscongenitaldb.org
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A palliative approach with conventional pulmonary artery
banding (PAB) is a common surgical option,particularly in smaller
infants and/or in the presence of associated anomalies, instead
of primary repair (1, 2, 4–10, 15, 16, 18–21, 31). However the
conventional PAB carries a high mortality. The hospital mortal-
ity in the 739 patients reported in the Congenital Database of
the European Association of Cardio-Thoracic Surgery (see text
footnote 1) was 8.9%. In addition, indication for conventional
PAB is limited by a series of drawbacks, particularly due to the
difficulty in determining the optimal tightening with a stable
and satisfactory balance between systemic and pulmonary cir-
culation to promote adequate growth (1, 2, 4–10, 15, 16, 18–21,
30–37).
After prolonged experimental studies (32) we introduced
the telemetrically adjustable FloWatch-PAB® (Leman Medical
Technologies, Lausanne, Switzerland) in the clinical practice in
2003. We and other institutions have since reported favorable
clinical results with its utilization in various congenital heart
defects (33–40).
This multicenter prospective study was conducted to eval-
uate a new strategy to treat infants with multiple VSDs with
FloWatch-PAB®.
MATERIALS AND METHODS
From 2004 to 2012 17 consecutive children (3 premature, 14
infants), mean age 3.2 months (range 9 days–9 months), mean
body weight 4.2 kg (range 3.1–6.1 kg), with multiple VSDs under-
went PAB with an adjustable FloWatch-PAB®.
Criteria for inclusion in this prospective study were infants
with the presence of multiple muscular apical VSDs (Swiss
cheese type), with or without associated congenital heart defects,
including the presence of other restrictive or unrestrictive VSD,
either of peri-membranous or inlet type. In the study period
no one infant with these characteristics underwent primary
repair.
All patients presented with multiple muscular apical VSDs,
associated with an additional large mid-muscular VSD in three
patients, a large peri-membranous VSD in two and a large inlet
VSD in one patient.
The diagnosis was established by echocardiography in all
infants, and 9/17 (53%) patients also underwent cardiac catheter-
ization and angiography.
The other associated cardiac anomalies are listed in Table 1.
Two infants had undergone previous cardiac surgery, one for
closure of patent ductus arterious and the other for closure of
patent ductus arterious with aortic coarctectomy, while one infant
had undergone interventional closure of patent ductus arteriosus
in cardiac catheterization laboratory.
One infant with Down syndrome had previously under-
gone non-cardiac surgery (colostomy) for an associated gastro-
intestinal malformation.
Five infants (5/17= 29.4%) required pre-operative mechanical
ventilation, with a mean duration of 64 days (range 7–240 days),
mostly due to the late referral for surgery from other institutions
or to the presence of recurrent respiratory infections.
The structural characteristics of the FloWatch-PAB® device,
mechanism of functioning, surgical technique of implantation,
Table 1 | Associated cardiac anomalies.
Number (%) Associated cardiac anomaly
12 (71) Patent ductus arteriosus
2 (12) Aortic coarctation
2 (12) Hypoplastic aortic arch
2 (12) Persistent left superior vena cava
1 (6) Left isomerism with polysplenia
1 (6) Cor triatriatum
1 (6) Partial anomalous pulmonary venous connection
and the procedures for post-operative percutaneous adjustments,
have all been previously reported (32, 33, 36, 37).
At the moment of the beginning of this prospective study the
device had already obtained the C.E. mark (equivalent in Europe to
the FDA approval for USA), after a multicenter prospective study
conducted through hospitals in different European countries (33).
Furthermore the FloWatch-PAB® had been successfully implanted
by the same surgical team in other congenital heart defects, and
therefore there was no need for approval by the institutional ethical
committee.
As for any other surgical procedure in the pediatric cardiac ser-
vice, written informed consent was obtained from the parents or
the legal guardian of all patients.
In all the patients described in this study the device was
implanted through a median sternotomy.
Nine patients underwent closure of an associated patent ductus
arteriosus at time of PAB.
Cardiopulmonary bypass was required in 3/17 (18%) infants,
in two for aortic arch reconstruction, and one for repair
of cor triatriatum and closure of a large associated peri-
membranous VSD.
In order to analyze the results of the study, the following data
were prospectively collected with a database prepared before the
beginning of the study and continuously updated:
(a) survival
(b) duration of post-operative mechanical ventilation
(c) length of stay in Intensive Care Unit (ICU)
(d) length of stay in hospital
(e) need for re-operation
(f) need for percutaneous adjustments of FloWatch-PAB®
(g) interval from implant to removal of FloWatch-PAB®
(h) evolution of the multiple muscular VSDs
For all patients the follow-up was censored at the last clinical
observation before December 2012.
RESULTS
There were no early or late deaths during a mean follow-up of
48 months, with a range from 7 to 98 months.
The mean duration of post-operative mechanical ventilation
was 2.4 days, with a range from 0 to 6 days.
The mean ICU and hospital stay were 5.6 (range 1–30 days) and
16.8 days (range 7–58 days) respectively.
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The relatively long interval (average 3.2 days) between the end
of the mechanical ventilation and the discharge from ICU was
due to the fact that in both institutions an intermediate step unit
between ICU and regular ward (High Dependency Unit) was not
available.
The only re-operation required after FloWatch-PAB® implanta-
tion was drainage of a pericardial effusion through a sub-xiphoid
approach in an infant who developed a pericardial effusion on
the eighth post-operative day after device implantation without
associated procedure.
All patients required percutaneous adjustments of the device
FloWatch-PAB®, with a mean of 4.8 times/patient (range from 2
to 9 times) to tighten the banding, and a mean of 1.1 times/patient
(range from 0 to 3 times) to lose the banding with the patient’s
growth. The decision to adjust the banding was in the immediate
post-operative period generally taken with progressive increase
of the tightening until reaching the wanted pressure gradient,
measured with Doppler echocardiography, providing normal dis-
tal pulmonary artery pressure with oxygen saturation >90% on
room air at pulse oximeter. In the late follow-up, with interval
evaluations dictated by the clinical conditions, adjustments of
the banding were required to lose the banding because of the
patient growth, with or without concomitant size reduction of
the multiple muscular VSDs.
After a mean interval of 29 months, with a range 8–69 months,
10 patients (10/17= 59%) underwent re-operation for FloWatch-
PAB® removal:
(a) seven patients underwent associated procedures: closure
of a remaining VSD in six: peri-membranous in three
patients, mid-muscular in two, and inlet in one Damus–
Kaye–Stansel, bi-directional Glenn, and atrial septectomy
in one
(b) three patients required only FloWatch-PAB® removal without
need for cardio-pulmonary bypass. In all these 10 patients pre-
operative echocardiography and/or cardiac catheterization
with angiography demonstrated closure of all the muscular
multiple VSDs.
Pulmonary artery reconstruction was not required in 9/10
(90%) patients, even with an interval between FloWatch-PAB®
implantation and removal up to 98 months. In only one
patient at the time of the FloWatch-PAB® removal the sur-
geon decided to perform a patch enlargement of the main pul-
monary artery because of a residual velocity of 3.2 m/s through
the main pulmonary artery on intra-operative echocardiographic
Doppler.
In five (5/7) of the remaining patients with FloWatch-PAB® still
in situ, at the last clinical observation with echocardiography all
the muscular VSDs had spontaneously closed. There are residual
muscular VSDs, however significantly reduced in size, still present
in the two patients both of whom have the shortest follow-up, of
7 and 25 months respectively.
Overall, including the patients with the FloWatch-PAB®
still in situ, the multiple muscular VSDs had closed in
15/17 (88.2%).
All devices were functioning at the moment of removal,
proven by the complete release of the banding before the surgical
procedure, as well as at the last follow-up, with device testing under
control by Doppler echocardiography.
DISCUSSION
REPAIR
The management of infants with multiple muscular VSDs is com-
plicated by the significant early and late mortality and morbidity
when primary surgical repair is undertaken (1, 2, 4–21).
The surgical closure of multiple muscular VSDs remains a
technically difficult procedure, due to inadequate exposure of the
defects, with or without a right or left ventriculotomy.
The surgical approach was simplified by the anatomical study
by Van Praagh showing the communication of the left ventric-
ular apex with the right ventricular apical infundibular recess
(11). Since then complete repair has been accomplished by several
groups through an appropriately placed right infundibulotomy,
providing adequate exposure to the multiple apical muscular VSDs
(1, 2, 7–9, 12, 17).
But even a limited right ventriculotomy may cause significant
damage to the ventricular muscle with deleterious consequences
on cardiac function and rhythm, with subsequent late morbidity
and mortality (2, 17).
The surgical approach through a left ventriculotomy continues
to have an elevated early mortality (5, 6, 21) and late morbidity
and mortality (5).
In addition, the cardiopulmonary bypass required for complete
repair in small infants, is still performed with the use of moderate
or severe hypothermia in most units. Hypothermia has delete-
rious effects on the reactive pulmonary vascular resistance, and
these effects in association with the presence of a right or left ven-
triculotomy can make the immediate post-operative course more
difficult.
HYBRID TECHNIQUES
The poor results initially reported with intra-operative device clo-
sure (22–25), with high mortality (14–25%) and failure rates (20–
40%) have recently become more encouraging in hospitals with
advanced facilities for hybrid techniques (26–30). This alterna-
tive technique remains still an option under evaluation in selected
institutions.
CONVENTIONAL PALLIATION
The palliative technique of conventional PAB not only is com-
plicated by high mortality and morbidity (1, 2, 4–10, 15, 16,
18–21, 31), but in addition is limited by a series of drawbacks,
particularly:
(a) difficulty in determining the optimal tightness of the band in
the presence of several other peri-operative variables related
to general anesthesia with positive pressure ventilation and
chest opening
(b) flow adjustment in children with increased pulmonary blood
flow, where the PAB is successful in controlling the distal
pressure but overflow persists
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(c) re-operations frequently required to adjust the band, includ-
ing some children who quickly outgrow a conventional
band
(d) long periods in an intensive care setting with respiratory
and/or pharmacological interventions to control pulmonary
blood flow
(e) frequent need for a reconstruction of the pulmonary artery at
the time of the conventional surgical de-banding for surgical.
To overcome the limitations of conventional PAB, after pro-
longed experimental studies (32) we introduced the telemetrically
adjustable FloWatch-PAB® in 2003. Since then there have been
reports also from other institutions as well, with favorable clinical
results in different types of congenital heart defects, including pal-
liation for bi-ventricular or uni-ventricular type of repair as well
as for left ventricular retraining (33–40).
PALLIATION WITH FLOWATCH-PAB®
The proven advantages provided by the telemetrically adjustable
FloWatch-PAB® over conventional PAB are smoother post-
operative period, without any requirement for delayed sternal
closure, shorter duration of post-operative mechanical ventilation,
ICU, and hospital stay (33–35, 37–39).
The improved outcomes with FloWatch-PAB® are the conse-
quence of the telemetrically controlled device, allowing repeated
graduated tightening of the PAB, thereby facilitating a controlled
and step-wise reduction of the pulmonary blood flow and pres-
sures, tailored to the clinical condition of the patient. In anes-
thetized infants it is difficult to instantaneously achieve adequate
control of pulmonary blood flow and pressure with the applica-
tion of a fixed conventional PAB: re-adjustments of the band are
often required, either with a re-operation or by leaving the chest
open for surgical adjustments in the ICU, with substantial risk of
mortality and morbidity. This is even more pronounced in very
sick infants requiring pre-operative mechanical ventilation and/or
additional lesions. The FloWatch-PAB® not only eliminates the
need of re-operation to adjust the band but also provides the abil-
ity to have precise and progressive tightening of the band over days
or weeks when the patient is awake and spontaneously breathing.
This can be performed on the ward or outpatient clinic, adjust-
ing the tightening according to the clinical condition and to the
trans-band pressure gradient measured with Doppler echocardio-
graphy. These are the main reasons why FloWatch-PAB® provides
better clinical results over conventional PAB with shorter ICU and
hospital stay, fewer complications, and costs reduction (33–35,
37–39).
An additional advantage of the non-circular shape of
the cross section of the FloWatch-PAB® is that reconstruc-
tion of the pulmonary artery after de-banding is generally
not required because the arterial wall remains pliable (36),
while following conventional PAB localized fibrosis of the pul-
monary artery wall almost always requires an extensive resec-
tion with patch reconstruction at the time of de-banding and
repair.
Taking into account all these advantages, we decided to evaluate
a new treatment strategy of infants with multiple VSDs using the
FloWatch-PAB® aimed at minimizing early and late mortality and
morbidity.
The results of our multicenter prospective study have demon-
strated that this approach provides excellent survival (100%), a
smooth post-operative course with short duration of mechanical
ventilation, ICU, and hospital stay, with very minimal morbidity.
As the band can be released as the patient grows, the mean inter-
val between first and second stage was 29 months, with a range
8–69 months. This interval not only allows a patient to reach an
age and body weight to better tolerate complete repair with lower
risk than in the first few weeks or months of life, but showed that
in the vast majority (88.2%) of the patients the multiple muscu-
lar VSDs had “spontaneously” closed over time, and no surgical
closure was necessary.
The reason for the “spontaneous” closure of the multiple mus-
cular VSDs over time has to be found in the hypertrophic reaction
of the inter-ventricular septum and the fibrosis accompanying
the long duration of the banding in situ. This occurred in both
groups of patients, with or without associated unrestrictive VSD,
either peri-membranous, mid-muscular, or inlet type. Of course,
while the first group, without associated unrestrictive VSD, didn’t
require any further surgery other than FloWatch-PAB® removal,
the patient with associated unrestrictive VSD required subsequent
operation to close the residual VSD, but at a later age and higher
body weight.
Finally, reconstruction of the main pulmonary artery at the
time of FloWatch-PAB® removal was required only in one patient.
As demonstrated in all previous reports, the pulmonary artery wall
remains pliable even after a long interval period (up to 69 months),
allowing total re-expansion and avoiding patch reconstruction (33,
36, 37, 39, 40).
LIMITS OF THE STUDY
This study is mainly limited by the absence of a control group.
During the same period of observation there was no homo-
geneous group of infants with the same characteristics who
underwent surgical repair or conventional PAB.
Because of our previous experience, we decided to offer initial
palliation with the FloWatch-PAB® to all infants with this diag-
nosis, and therefore our comparison has been made with the data
provided by the literature.
CONCLUSION
This reproducible new strategy with adjustable FloWatch-PAB®
simplifies the management of infants with multiple muscular
VSDs and provides the following advantages:
(a) good results (0% mortality)
(b) delayed surgery with a high incidence (88%) of spontaneous
closure of multiple muscular VSDs
(c) facilitated closure of residual unrestrictive VSD (peri-
membranous, mid-muscular, or inlet) at an older age and
higher body weight
(d) PAB application and late removal can potentially be the only
procedures required for Swiss cheese multiple VSDs without
associated peri-membranous unrestrictive VSD.
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